Business Context and Reporting Period
Company: Bone Biologics Corp (BBLG)
Filing Type: Form 8-K (Current Report)
Date of Report: July 15, 2026
Event: Postponement of the 2026 Annual Meeting of Stockholders.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a notice of a corporate governance event.
Material Changes
- Annual Meeting Date: Postponed from August 11, 2026, to September 28, 2026.
- Meeting Time: 11:30 a.m. Eastern Time.
- Location: Company offices at 2 Burlington Woods Drive, Ste 100, Burlington, MA 01803.
- New Record Date: August 6, 2026.
- Reason for Change: The Board intends to include an additional proposal in the Definitive Proxy Statement (Schedule 14A) and determined that additional time is necessary for stockholders to consider the materials.
Guidance, Outlook, and Risks
Management Commentary: The Board explicitly stated the need for additional time for stockholder consideration of proxy materials due to the addition of a new proposal.
Deadlines: The deadline for stockholder submissions of director nominees or other business proposals is now July 26, 2026 (ten calendar days following the date of this report).
Risks/Contingencies: No specific financial risks or contingencies are disclosed in this filing.
Key Facts for Investor Verification
- Verify the new Annual Meeting date of September 28, 2026, and the new record date of August 6, 2026.
- Monitor the upcoming Schedule 14A Definitive Proxy Statement for details on the "additional proposal" cited as the reason for the postponement.
- Note the new deadline of July 26, 2026, for submitting stockholder proposals or director nominees.